Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 31, 2008American Journal of TransplantationOpen Access

The Use of Antibody to Complement Protein C5 for Salvage Treatment of Severe Antibody-Mediated Rejection

View Full Paper
Ask AI
Bookmark
Share

Authors

JLJayme E. LockeUniversity of Alabama at BirminghamCMCynthia M. MagroCornell UniversityASA.L. SingerWinnMed

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Locke et al. (2008) studied this question.

synapsesocial.com/papers/6aa950fb1ed6af7fb80e1527https://doi.org/10.1111/j.1600-6143.2008.02451.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1THE LATE ADVERSE EFFECT OF SPLENECTOMY ON PATIENT SURVIVAL FOLLOWING CADAVERIC RENAL TRANSPLANTATION1984 · 54 citations
  2. 2Plasmapheresis, CMV Hyperimmune Globulin, and Anti-CD20 Allow ABO-Incompatible Renal Transplantation Without Splenectomy2004 · 283 citations
  3. 3IVIG and HLA Antibodies. Evidence for Inhibition of Complement Activation but Not for Anti‐Idiotypic Activity2005 · 41 citations
  4. 4Rituximab as Treatment for Refractory Kidney Transplant Rejection2004 · 308 citations
  5. 5The Utility of Splenectomy as Rescue Treatment for Severe Acute Antibody Mediated Rejection2007 · 128 citations